Streetbeat News

Earnings

OLPX

Olaplex reported better-than-expected Q3 financial results and revised its FY23 revenue guidance above estimates, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:11 pm

GEO

The GEO Group Inc reported Q3 FY23 revenue of $602.8 million, beating the consensus of $595.3 million. Adjusted EPS of $0.19 came in line with the consensus. The company reduced total net debt by $109 million, ending the quarter with approximately $1.8 billion in total net debt. GEO lowered its Q4 revenue outlook to $590 million-$600 million and revised its FY23 Adjusted EBITDA outlook to $495 million-$500 million. The company's shares are trading higher by 4.13% at $9.32.

Portfolio Pulse from Lekha Gupta

November 07, 2023 | 6:08 pm

ELAN

Elanco Animal Health Inc (ELAN) reported Q3 FY23 revenue of $1.068 billion, surpassing the consensus of $1.04 billion. Adjusted EPS was $0.18, up from $0.17 a year ago, beating both management guidance and analysts' expectations. The company raised its FY23 revenue guidance to $4.36 billion-$4.4 billion. ELAN shares are up 13.30% at $10.60.

Portfolio Pulse from Vandana Singh

November 07, 2023 | 6:04 pm

OLO

Olo's shares are trading lower following the release of its Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:04 pm

BNGO

Bionano Genomics (NASDAQ:BNGO) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.94. The company's past performance shows a trend of missing EPS estimates, which has led to share price drops. The stock is currently trading at $1.63, down 92.9% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 6:02 pm

MTNB

Matinas BioPharma Hldgs (AMEX:MTNB) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.03. The company's past performance shows a trend of missing EPS estimates, which has led to significant drops in share price. The company's shares are currently trading at $0.2516 and have seen a 60.21% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 6:02 pm

LTRN

Lantern Pharma (NASDAQ:LTRN) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.45. The company's past performance shows a mixed trend of beating and missing EPS estimates, with corresponding changes in share price. The stock is currently trading at $2.95, down 30.89% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 6:02 pm

AVIR

Atea Pharmaceuticals (NASDAQ:AVIR) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.48. The company's past performance shows a pattern of beating EPS estimates, which has sometimes led to an increase in share price. However, the stock has been down 32.7% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 6:01 pm

SMSI

Smith Micro Software (NASDAQ:SMSI) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $0.00. The company's past performance shows a mixed trend of EPS estimates and actuals, with the share price reacting accordingly. The stock is currently trading at $1.08, down 48.49% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 6:01 pm

STRR

Star Equity Hldgs (NASDAQ:STRR) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.12. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. The stock is currently trading at $0.93 and has seen a 17.08% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 6:01 pm